semaglutide 503b exclusion

FDA to exclude semaglutide, tirzepatide and liraglutide on 503B bulks list — Photo by Artem Podrez on Pexels

Semaglutide 503B Exclusion: Are You Paying More?

Semaglutide 503B Exclusion: Are You Paying More? A rural community could see a 15-20% hike in monthly weight-loss drug costs within weeks. The surge is driven by the FDA's decision to pull semaglutide, tirzepatide and liraglutide from the 503B bulk-drug list, forcing pharmacies to source higher-priced alternatives. Medical